Aptevo Therapeutics Inc Sustainability Reports
Aptevo Therapeutics Inc. is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of cancer. The company utilizes its proprietary ADAPTIR and ADAPTIR-FLEX modular protein technology platforms to engineer bispecific and trispecific antibodies that modulate the immune system to target tumor cells.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900UTQOXOZBMZFN24
FIGI: BBG009RRZ8D1
7 reports from 2016 to 2024
